Axonics Inc (AXNX) Stock News
NASDAQ:AXNX - Nasdaq - US05465P1012 - Common Stock - Currency: USD
AXNX Latest News, Press Relases and Analysis
Boston Scientific Closes Acquisition of Axonics, Inc.
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a medical technology...
Mentions: BSX
Axonics Reports Third Quarter 2024 Financial Results
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
Axonics Prevails in Patent Infringement Lawsuit with Medtronic
AXNX Stock Earnings: Axonics Misses EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Axonics (NASDAQ:AXNX) just reported results for the first quarter of 2024.Axoni...
Axonics Reports Second Quarter 2024 Financial Results
7 Robotics Stocks That Could Grow Your Wealth
Explore robotics stocks with the potential to grow investors' wealth as the industry expands across various sectors.
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
AXNX Stock Earnings: Axonics Misses EPS, Beats Revenue for Q1 2024
AXNX stock results show that Axonics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Why Axonics Stock Soared Today
The medical device maker agreed to be acquired by Boston Scientific.
Mentions: BSX
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.
/PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Axonics, Inc. (NASDAQ: AXNX) and its board of directors concerning the...
Mentions: BSX
Axonics Reports First Quarter 2024 Financial Results
Boston Scientific Announces Results for First Quarter 2024
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a...
Mentions: BSX
Axonics Stockholders Approve Merger Agreement with Boston Scientific
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
Boston Scientific Likely Faces FTC Scrutiny on $3.7 Billion Axonics Deal
Boston Scientific Corp.’s proposed $3.7 billion acquisition of medical device maker Axonics Inc. will likely be scrutinized by the US Federal Trade Commission because the companies are the dominant providers of some treatments for urinary incontinence, according to antitrust experts.
Mentions: BSX
Medtronic accuses Axonics of patent infringement, files ITC complaint (NASDAQ:AXNX)
Medtronic (MDT) has filed a complaint with the US International Trade Commission and a U.S. District Court accusing Axonics (AXNX) of patent infringement. Read more here.
Mentions: MDT
Axonics Responds to ITC Action by Medtronic
Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.725 billion during the fourth quarter of 2023, growing 14.9 percent on a...
Mentions: BSX
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review
The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut.
10 Top Stocks With a Strong Buy Rating Right Now
Wall Street is highly bullish on these strong buy stocks, even as financial markets face an uncertain year. Here are the names to watch.